Technical Information

 

“Canine joint therapy with Synovetin OA™ has early disease-modifying effects by breaking the inflammatory cycle associated with synovitis” Technical Bulletin

“Canine joint therapy with Synovetin OA™ has early disease-modifying effects by breaking the inflammatory cycle associated with synovitis” Technical Bulletin

“Radiosynoviorthesis: A new therapeutic and diagnostic tool for canine joint inflammation” Technical Bulletin

“Radiosynoviorthesis: A new therapeutic and diagnostic tool for canine joint inflammation” Technical Bulletin

“Safety and effectiveness of Synovetin OA™: Results of three randomized trials evaluating treatment of naturally occurring canine elbow osteoarthritis” Technical Bulletin

“Safety and effectiveness of Synovetin OA™: Results of three randomized trials evaluating treatment of naturally occurring canine elbow osteoarthritis” Technical Bulletin

RAM Navigator Program Brochure

Exubrion Therapeutics Corporate Overview

Inflammatory Cycle

Inflammatory Cycle

RAM Navigator

RAM Navigator Program Brochure

Synovetin OA™ Product Overview

Synovetin OA™ Product Overview

Tin-117m Spec Sheet

Tin-117m Spec Sheet

Synovetin OA™ delivers sustained OA pain relief.1

Learn about once-yearly treatment

Synovetin OA™ provides targeted, non-systemic therapy.2

Review the safety data

References:

  1. Data on file, Exubrion Therapeutics.
  2. Donecker JM, Fox SM. Safety and effectiveness of Synovetin OA™: Results of three randomized trials evaluating treatment of naturally occurring canine elbow osteoarthritis. Exubrion Therapeutics, July 2019.